[New aspects of infections caused by Aspergillus and Mucor and other filamentous fungi in immunosuppressed patients].
Bouza
E
E
Servicio de Microbiología Clínica y Enfermedades Infecciosas, General Universitario Gregorio Marañón, Universidad Complutense, Madrid.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D005658:Fungi / Q000302:isolation & purification; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male; D009091:Mucormycosis / Q000175:diagnosis / Q000188:drug therapy; D015337:Multicenter Studies as Topic; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D010531:Peritoneal Dialysis, Continuous Ambulatory
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole